This paper explores the current understanding and clinical applications of biologics, such as bone graft substitutes and growth factors, in enhancing the healing of problematic fractures, with specific insights from Yemeni clinical experience. It reviews the scientific rationale and emerging evidence for these adjunct therapies.
